Grant: Collaborative Health Research Projects
University of British Columbia
$200,000.00
Transcutaneous microsphere vaccine technology
FY 2014-15
Summary
Common ""killed"" microbe vaccines such as hepatitis vaccine, must be given repeatedly to be effective. Influenza vaccinemust be given yearly. This is costly and inconvenient. In recent work we have shown that vaccines can be incorporated intodissolving spheres that release bursts of vaccine in the skin at timed intervals. We will use this system to obtain the sameeffect as repeated administration, but with a single administration. The spheres will be delivered into the skin painlesslyusing new microscopic hollow needles that allow painless administration. We plan to optimize this new method ofvaccination by combining the skills of an immunologist, a pharmacy scientist, a mechanical engineer and a clinicalvaccinologist. The projected advantages of this new vaccine system are lowered cost, pain free administration, andincreased efficacy
Program
Collaborative Health Research Projects
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
446570-2013
Name nom
Dutz, Jan
Department département
Dermatology and Skin Science
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
200000
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Transcutaneous microsphere vaccine technology
Keyword
NSERC
Application summary
Common ""killed"" microbe vaccines such as hepatitis vaccine, must be given repeatedly to be effective. Influenza vaccinemust be given yearly. This is costly and inconvenient. In recent work we have shown that vaccines can be incorporated intodissolving spheres that release bursts of vaccine in the skin at timed intervals. We will use this system to obtain the sameeffect as repeated administration, but with a single administration. The spheres will be delivered into the skin painlesslyusing new microscopic hollow needles that allow painless administration. We plan to optimize this new method ofvaccination by combining the skills of an immunologist, a pharmacy scientist, a mechanical engineer and a clinicalvaccinologist. The projected advantages of this new vaccine system are lowered cost, pain free administration, andincreased efficacy